Latest Capital Raises News

Prescient Therapeutics has raised nearly $10 million through a placement and share purchase plan to advance its promising PTX-100 targeted cancer therapy into pivotal clinical stages.

Astute Metals NL has successfully raised $5.5 million through an oversubscribed placement to advance its Nevada lithium and gold projects, including a maiden resource estimate and new drilling campaigns.

AGUIA RESOURCES reported a $1.2 million net increase in cash for Q2 2025, underpinned by financing activities, as it prepares to launch underground operations at its Santa Barbara Mine.

Sky Metals Limited has locked in $6.1 million through a share placement to accelerate exploration and development at its flagship Tallebung Tin Project in NSW. The funding will support resource expansion, metallurgical studies, and feasibility work.

Aguia Resources reported steady progress in its June 2025 quarter, highlighting underground gold production in Colombia and development milestones in Brazil’s phosphate project, alongside strategic capital raises and operational restructuring.

InteliCare Holdings reported a $564,000 operating cash outflow in Q4 2025 and has secured $1 million in additional funding to support ongoing operations despite a cash runway under one quarter.

Energy Metals Limited reported steady progress in its uranium exploration projects during the June 2025 quarter, supported by a strong cash position and rising uranium prices. Preparations to refresh the Bigrlyi Pre-Feasibility Study and regional exploration groundwork highlight the company’s strategic focus.

Australian Critical Minerals has acquired six exploration projects in Peru, significantly broadening its portfolio with targets in gold, copper, silver, base metals, and lithium. The company also completed a $1 million capital raise to fund upcoming exploration activities.

HALO Technologies reports $3.54 million in Q2 revenue with rising subscription income, progressing UK expansion pending FCA approval, and a $6.75 million capital raise nearing completion.

Galilee Energy reported operational cost reductions and a $2.8 million cash balance following a partial capital raise, while progressing a farm-out process for its Denison Trough permit.

Imugene Limited reports strong clinical progress with its off-the-shelf CAR T therapy azer-cel achieving a 75% overall response rate in Phase 1b trials, alongside new patents and leadership appointments. The company also secured $22.5 million in fresh funding to advance pivotal trials.

Strategic Energy Resources has secured $2 million through a share placement to acquire the Diamantina Copper-Gold Project and advance drilling programs across Queensland. The capital raise signals renewed momentum in the company’s copper-gold exploration strategy.